Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Delequamine

Copy Product Info
😃Good
Catalog No. T68051Cas No. 119905-05-4
Alias RS 15385-197

Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.

Delequamine

Delequamine

Copy Product Info
😃Good
Purity: 99.96%
Catalog No. T68051Alias RS 15385-197Cas No. 119905-05-4
Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$258In StockIn Stock
5 mg$647In StockIn Stock
10 mg$919In StockIn Stock
25 mg$1,380In StockIn Stock
50 mg$1,860In StockIn Stock
100 mg$2,490In StockIn Stock
500 mg$4,930-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.96%
ee:100%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Delequamine AI Summary
Delequamine exhibits a high binding affinity to the alpha-1 adrenergic receptor with a Ki value of 10232.93 nM and an even higher binding affinity to the alpha-2 adrenergic receptor, as shown by its Ki value of 0.6607 nM. It demonstrates notable in vitro activity by reversing the inhibitory effect of UK-14304 on the contractile response of guinea pig ileum with a Kd value of 0.1995 nM. In vivo, Delequamine effectively inhibits clonidine-induced mydriasis in rats, with an ID50 of 0.013 mg/kg following intravenous administration and 0.21 mg/kg following oral administration. Remarkably, it shows high selectivity for the alpha-2 adrenergic receptor over the alpha-1 adrenergic receptor, with a selectivity ratio of 15000.0..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.
Targets&IC50
α1-adrenoceptor:5.3 (pKi), α2-adrenoceptor:9.5 (pKi)
SynonymsRS 15385-197
Chemical Properties
Molecular Weight350.48
FormulaC18H26N2O3S
Cas No.119905-05-4
SmilesS(C)(=O)(=O)N1[C@]2(C[C@]3(C=4C(=CC(OC)=CC4)CCN3C[C@]2(CCC1)[H])[H])[H]
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Delequamine | purchase Delequamine | Delequamine cost | order Delequamine | Delequamine chemical structure | Delequamine formula | Delequamine molecular weight